Adcendo

As we are moving forward a pipeline of drug candidates of the ADC class, Adcendo continues to grow! 🤝 We are therefore looking for an in-house talent acquisition specialist or consultant, to help coordinate and execute our recruiting and onboarding plans. The role is time-limited, and fit for consultancy or as a part-time role, and candidates/consultants with the option of joining us on-site and in-person here in Copenhagen will be preferred. If you are a talented recruiter or recruiting consultant with good insights into the biotech industry, this is an opportunity to join and help an international company grow into the next stage, at a truly exciting time. If you can see yourself in this role, or if you are interested in learning more, you are welcome to contact our HR Director via the mail address [email protected], and to share a CV as well as other relevant details. 📧 We will naturally fill the role as soon as possible. Please note that this opportunity is not posted elsewhere as a job ad, and cannot be found as an open position on the LinkedIn Jobs section. Apply via e-mail. #TalentAcquisition #Oncology #WeAreHiring #Recruiter 

We are seeking a toxicologist to join our team as Associate Director/Director of Toxicology. At Adcendo, we are dedicated to developing highly differentiated antibody-drug conjugates (ADCs) for the treatment of underserved cancers. We pride ourselves on being at the forefront of cutting-edge technologies and solutions, and our commitment to excellence sets us apart. As Associate Director/Director of Toxicology you will be responsible for all Toxicology & Safety aspects of selected Adcendo ADC programs. You will work closely with our pre-clinical & clinical departments to support the progression of product candidates all the way from late-stage research through to pivotal human clinical trials. We offer an international work environment that fosters innovation and rewards excellence. This is a fantastic opportunity to contribute to the future of cancer treatment as part of a forward-thinking company! Find more details about the job and how to apply: https://lnkd.in/dwH2k4Hu #Toxicology #Adcendo #Cancer #ADC #CareerOpportunity #JobOpening

Please do not miss this open opportunity for joining Adcendo as a #toxicologist. Do not hesitate to us apply via LinkedIn or e-mail, as we aim to kick off interviews after the holiday weeks.

Adcendo Stands with the Sarcoma Community: Advancing Innovation for a Brighter Future This July, as we observe Sarcoma Awareness Month, Adcendo reaffirms our commitment to the global fight against sarcoma. Sarcoma Awareness Month is a powerful reminder of the strength and resilience of those affected by this rare group of cancers, and it is a call to action for all to raise awareness and drive innovation. At Adcendo, we are pioneering the development of Antibody-Drug Conjugates (ADCs) specifically designed to target rare cancers such as sarcomas. Our mission is to transform the treatment landscape for sarcoma patients by harnessing the power of ADC technology to deliver targeted, effective therapies. Our lead program focuses on uPARAP (urokinase plasminogen activator receptor-associated protein), a novel and promising target for cancer treatment, underscoring our dedication to addressing the unmet needs in sarcoma care. We believe that through cutting-edge research and collaboration, we can make a significant impact. This Sarcoma Awareness Month, we invite patients, families, caregivers, healthcare professionals, researchers, policymakers, and the broader community to join us in our mission. Together, we can honour those who have battled sarcoma, support those currently fighting, and work towards a future where early detection, effective treatment, and ultimately, a cure for sarcoma, are within reach. Join Adcendo in standing with the sarcoma community and reinforcing our collective commitment to innovative cancer treatment solutions. #SarcomaAwarenessMonth #Adcendo #InnovationInAction #CancerResearch #ADCTechnology #HopeForACure

Please join us in welcoming our newest team member, Sandra Thomas Frederiksen, who has joined us as Executive Assistant. Her extensive experience supporting leaders in the Biotech industry will undoubtedly contribute to our success! Welcome to Adcendo, Sandra! We look forward to the exciting journey ahead as we make strides towards better treatment of cancer. 🚀 Follow our Company LinkedIn page for news and information about upcoming open positions. #Adcendo #NewHire #CancerResearch #ADCs #ExecutiveAssistant #WeAreGrowing

Join Adcendo as our new Assoc. Director / Director, Business Development and Alliance Management. 🚀 At Adcendo, we are dedicated to developing highly differentiated antibody-drug conjugates (ADCs) for the treatment of underserved cancers. We pride ourselves on being at the forefront of cutting-edge technologies and solutions, and our commitment to excellence sets us apart. We offer an international work environment that fosters innovation and rewards excellence. This is a fantastic opportunity to contribute to the future of cancer treatment as part of a forward-thinking company! Find more details about the job and how to apply: https://lnkd.in/dCsPmvNw   #BusinessDevelopment #AllianceManagement #Adcendo #CareerOpportunity #JobOpening

Great to see our CEO, Michael Pehl, highlighted by Clarivate following the publication of its 'Companies to Watch: Antibody Drug Conjugates' report! https://lnkd.in/dbTeNsct Learn more about Adcendo and our development of first-in-class #ADCs for the treatment of #cancer with a high unmet medical need in the report here: https://lnkd.in/eWhSzAWz #biotech #oncology #lifesciences

📣 Adcendo has been featured in Clarivate for Life Sciences & Healthcare's "Companies to Watch: Antibody Drug Conjugates" report! 📰 The report highlights this exciting field of therapeutics and shines a spotlight on companies making an impact in the #lifesciences and #healthcare space. Adcendo is highlighted as one of seven companies that are advancing antibody-drug conjugates (#ADCs) to deliver highly targeted cancer treatments with an improved therapeutic window. Find out more about what makes us stand out, our R&D activities to date, and much more in the report here: https://lnkd.in/eWhSzAWz #biotech #oncology #lifesciences

📣Adcendo today announces an extension of its Series A financing, raising its total funds raised to €98 million to further bolster its first-in-class #ADC pipeline and expand development of its lead uPARAP program in soft tissue sarcoma and other mesenchymal cancers!📣   The financing was led by Dawn Biopharma, a platform controlled by KKR, with participation from existing investors Novo Holdings, Ysios Capital, RA Capital Management, HealthCap, Gilde Healthcare and Pontifax Venture Capital.   As part of the financing, Iyona Rajkomar of Dawn Biopharma will join the Adcendo Board of Directors, bringing a wealth of experience in advancing early- and clinical-stage biotechs.   Learn more about the #financing and what it means for Adcendo in the press release linked below! https://lnkd.in/exnRSsFP   #biotech #cancer #oncology #lifesciences #companygrowth

In Adcendo, we are continuing our path towards becoming a clinical-stage biotech by the end 2024, moving forward a pipeline of several drug candidates of the ADC class. This means that we are growing. One of the next positions we will add to our team is a Head of Quality to spearhead the quality strategy within the GXP areas, including non-clinical, clinical and CMC activities.   If you have substantial experience supporting oncology focused biotech companies in a similar role and would be interested in learning more or have a brief confidential talk about the role, you are welcome to contact our HR director at [email protected]. #HeadofQuality #Oncology #Biotech #WeAreHiring